However, in co-transplantation with RCC cells, the tumor-derived CD133+ cells favored vascularization and enhanced tumor growth rather than initiating tumor growth of their own lineage in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice [84]. This evidence concerns the gene PROM1 and renal cell carcinoma.